GlassScriptPhysician profile
James R Larzalere
NPI 1184690695
$1,255.75
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $255 · 2021: $381 · 2022: $166 · 2023: $185 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $276.95 | 2019-2024 | Breztri, Airsupra |
| Lilly USA, LLC | $139.15 | 2019-2023 | Jardiance, Emgality |
| Eisai INC. | $105.41 | 2020-2021 | |
| Novo Nordisk INC | $95.89 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.31 | 2019-2020 | |
| Amgen INC. | $79.32 | 2021-2022 | |
| Abbvie INC. | $68.68 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $50.28 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $49.91 | 2020-2021 | |
| Dexcom, INC. | $48.08 | 2021-2023 | Dexcom G6 Transmitter |
| Adamas Pharmaceuticals, INC. | $46.88 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $41.65 | 2019-2022 | |
| Pfizer INC. | $34.77 | 2019-2023 | |
| Astellas Pharma US INC | $32.28 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $30.86 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $28.43 | 2019-2022 | |
| Mylan Specialty L.P. | $15.81 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.82 | 2019 | |
| Genentech USA, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Larzalere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.